The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

The American College of Cardiology (ACC) has a long history of developing documents (eg,
decision pathways, health policy statements, appropriate use criteria) to provide members …

Aims Effective and safe decongestion remains a major goal for optimal management of
patients with acute heart failure (AHF). The effects of the sodium–glucose cotransporter 2 …

The purpose of this manuscript is to review the effects of sodium-glucose cotransport protein
2 inhibitors (SGLT2is) in patients with chronic kidney disease according to basic …

Importance Clinical guidelines for patients with heart failure with reduced ejection fraction
(HFrEF) strongly recommend treatment with a sodium-glucose cotransporter-2 inhibitor …

Acute heart failure is a major cause of urgent hospitalizations. These are followed by marked
increases in death and rehospitalization rates, which then decline exponentially though they …

Heart failure (HF) remains one of the most common causes of hospitalization and mortality
among Polish patient s. The position of the Section of Cardiovascular Pharmacotherapy …

The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

ABSTRACT Introduction Sodium Glucose co-Transporter 2 (SGLT2) inhibitors (also known
as 'gliflozins') represent a cornerstone to treat diabetes mellitus. Moreover, recent …

Purpose Both heart failure and its treatment with diuretics or SGLT2 inhibitors increase fall
risk in older adults. Therefore, decisions to continue or deprescribe diuretics or SGLT2 …